EMulate Therapeutics Announces the Publication of Positive Pre-clinical Data Evaluating Pain Reduction via Delivery of Low and ...
BELLEVUE, Wash., Oct. 18, 2022 (GLOBE NEWSWIRE) -- EMulate Therapeutics, a clinical-stage, life sciences, digital therapeutics company developing safe, non-invasive, and highly effective treatments for cancers and other serious diseases, today announced …